XBiotech Inc.
XBIT
$2.42
-$0.02-0.82%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.90% | -18.19% | 10.72% | 19.55% | -28.20% |
| Total Depreciation and Amortization | -10.20% | -3.38% | 0.40% | 1.50% | 1.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -117.30% | -95.96% | 202.01% | 2.30% | 177.87% |
| Change in Net Operating Assets | -80.03% | 349.49% | -299.06% | -158.07% | -124.32% |
| Cash from Operations | -38.35% | -28.93% | 15.61% | -6.79% | -44.33% |
| Capital Expenditure | 82.94% | 77.84% | 74.61% | 44.95% | -87.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 83.73% | 77.84% | 74.61% | -100.93% | -101.87% |
| Total Debt Issued | -- | -- | -97.50% | -97.50% | -97.50% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -80.24% | -10.19% | 141.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -198.09% | -198.03% | -197.97% | -198.10% |
| Foreign Exchange rate Adjustments | 152.33% | 160.28% | -3,853.06% | 98.78% | -126.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.42% | -72.33% | -87.44% | -178.85% | -192.97% |